Forefront Analytics, LLC
13F Reported Value
ⓘ$110.0M
Holdings
39
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Forefront Analytics, LLC disclosed 39 positions worth $110.0M in its Form 13F-HR for Q1 2026, followed by $MUFG. During the quarter the fund opened 4 new positions and exited 2. The portfolio is most concentrated in Other (75.8% of disclosed assets). All figures are sourced directly from Forefront Analytics, LLC’s Form 13F-HR filing with the SEC under CIK 1696802.
AI Fund Analysis
Concentrating
$MUFG
$DE
$ABT
$PMSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
ISHARES TR
—Quality
$24.3M254,427 sh- $16.8M369,453 sh
VANGUARD INTL EQUITY INDEX F
—Quality
$9.7M180,162 shISHARES TR
—Quality
$9.2M68,087 shNUSHARES ETF TR
—Quality
$8.9M195,657 shFLEXSHARES TR
—Quality
$8.8M44,239 shDBX ETF TR
—Quality
$6.3M126,892 shISHARES TR
—Quality
$5.8M24,234 shVANGUARD TAX-MANAGED FDS
—Quality
$3.0M47,307 shISHARES TR
—Quality
$2.9M4,474 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| ISHARES TR | — | $24.3M | 254,427 |
| MITSUBISHI UFJ FINANCIAL GROUP INC$MUFG | — | $16.8M | 369,453 |
| VANGUARD INTL EQUITY INDEX F | — | $9.7M | 180,162 |
| ISHARES TR | — | $9.2M | 68,087 |
| NUSHARES ETF TR | — | $8.9M | 195,657 |
| FLEXSHARES TR | — | $8.8M | 44,239 |
| DBX ETF TR | — | $6.3M | 126,892 |
| ISHARES TR | — | $5.8M | 24,234 |
| VANGUARD TAX-MANAGED FDS | — | $3.0M | 47,307 |
| ISHARES TR | — | $2.9M | 4,474 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Forefront Analytics, LLC's 39 positions.
Showing top 10 of 39 holdings.
Sector Allocation
Other
$83.4M
Financials
$18.7M
Healthcare
$4.0M
Technology
$3.0M
Industrials
$640,159
Consumer Staples
$239,664
Full Holdings — Forefront Analytics, LLC (Q1 2026)
All 39 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | ISHARES TR | $24.3M | 22.1% | +20% | — |
| 2 | $MUFG | MITSUBISHI UFJ FINANCIAL GROUP INC | $16.8M | 15.3% | +2% | — |
| 3 | — | VANGUARD INTL EQUITY INDEX F | $9.7M | 8.9% | -1% | — |
| 4 | — | ISHARES TR | $9.2M | 8.4% | -2% | — |
| 5 | — | NUSHARES ETF TR | $8.9M | 8.1% | +38% | — |
| 6 | — | FLEXSHARES TR | $8.8M | 8.0% | +92% | — |
| 7 | — | DBX ETF TR | $6.3M | 5.7% | -1% | — |
| 8 | — | ISHARES TR | $5.8M | 5.3% | -52% | — |
| 9 | — | VANGUARD TAX-MANAGED FDS | $3.0M | 2.8% | -62% | — |
| 10 | — | ISHARES TR | $2.9M | 2.7% | -5% | — |
| 11 |  $NVDA | NVIDIA CORP | $2.5M | 2.3% | +2% | 90.2 |
| 12 | — | ISHARES INC | $2.2M | 2.0% | -3% | — |
| 13 |  $JPM | JPMORGAN CHASE & CO | $1.5M | 1.3% | +49% | 35.6 |
| 14 | $DE | DEERE & CO | $640,159 | 0.6% | +0% | 57.4 |
| 15 |  $UNH | UNITEDHEALTH GROUP INC | $536,559 | 0.5% | +37% | 66.8 |
| 16 |  $EW | Edwards Lifesciences Corp | $526,446 | 0.5% | +8% | 67.6 |
| 17 | $ABT | ABBOTT LABORATORIES | $517,726 | 0.5% | +34% | 67 |
| 18 |  $WT | WisdomTree, Inc. | $477,881 | 0.4% | -54% | 62.9 |
| 19 | — | SCHWAB STRATEGIC TR | $463,851 | 0.4% | NEW | — |
| 20 |  $MDT | Medtronic plc | $460,894 | 0.4% | +24% | — |
| 21 | — | PROSHARES TR | $423,564 | 0.4% | +0% | — |
| 22 |  $INCY | INCYTE CORP | $398,410 | 0.4% | -19% | 81.2 |
| 23 | — | PROSHARES TR | $372,900 | 0.3% | +0% | — |
| 24 |  $PFE | PFIZER INC | $367,578 | 0.3% | -31% | 69 |
| 25 |  $OTF | Blue Owl Technology Finance Corp. | $367,413 | 0.3% | NEW | — |
| 26 |  $REGN | REGENERON PHARMACEUTICALS, INC. | $355,029 | 0.3% | +8% | 75.1 |
| 27 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $284,553 | 0.3% | -1% | 63.7 |
| 28 |  $LEGN | Legend Biotech Corp | $283,271 | 0.3% | NEW | 44.2 |
| 29 | — | VANGUARD INDEX FDS | $258,473 | 0.2% | -62% | — |
| 30 |  $DHR | DANAHER CORP /DE/ | $244,168 | 0.2% | +41% | 63.9 |
| 31 | $PM | Philip Morris International Inc. | $239,664 | 0.2% | +1% | 80.5 |
| 32 | — | DIMENSIONAL ETF TRUST | $222,189 | 0.2% | NEW | — |
| 33 |  $NKTX | Nkarta, Inc. | $92,492 | 0.1% | +8% | — |
| 34 |  $ZURA | Zura Bio Ltd | $88,661 | 0.1% | -24% | — |
| 35 |  $GERN | GERON CORP | $82,136 | 0.1% | +7% | — |
| 36 |  $ANNX | Annexon, Inc. | $78,890 | 0.1% | +8% | — |
| 37 |  $BCYC | BICYCLE THERAPEUTICS PLC | $66,788 | 0.1% | +8% | — |
| 38 |  $CTMX | CytomX Therapeutics, Inc. | $58,637 | 0.1% | -33% | 19.1 |
| 39 |  $MREO | Mereo BioPharma Group plc | $42,167 | 0.0% | +302% | — |
New Positions (4)
Exited Positions (2)
$MIRM Mirum Pharmaceuticals, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Forefront Analytics, LLC including:
Track Forefront Analytics, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Forefront Analytics, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Forefront Analytics, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Forefront Analytics, LLC (SEC CIK: 1696802), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Forefront Analytics, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.